A randomized placebo-controlled trial of electroencephalographic (EEG) neurofeedback in children with attention-deficit/hyperactivity disorder

Journal of Clinical Psychiatry

Volumn 74, Issue 8, 2013, Pages 821-827

  Van Dongen Boomsma, Martine ^a,b   Vollebregt, Madelon A ^a,b   Slaats Willemse, Dorine ^a,b   Buitelaar, Jan K ^a,b  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; PLACEBO; PSYCHOSTIMULANT AGENT;

ADOLESCENT; AGE DISTRIBUTION; AROUSAL; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DSM-IV-TR; ELECTROENCEPHALOGRAPHIC NEUROFEEDBACK; FEMALE; HUMAN; MALE; NETHERLANDS; NEUROFEEDBACK; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHOOL CHILD; TREATMENT RESPONSE;

EID: 84883173642     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.12m08321     Document Type: Article

References (32)

1. Brown RT, Amler RW, Freeman WS, et al American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. Pediatrics. 2005;115(6):e749-e757.
2. Graham J, Banaschewski T, Buitelaar J, et al European Guidelines Group. European guidelines on managing adverse effects of medication for ADHD. Eur Child Adolesc Psychiatry.2011;20(1):17-37.
3. Spencer TJ, Biederman J, Wilens TE, et al. Novel treatments for attention-deficit/hyperactivity disorder in children. J Clin Psychiatry. 2002;63(suppl 12):16-22.
4. van de Loo-Neus GH, Rommelse N, Buitelaar JK. To stop or not to stop? how long should medication treatment of attention-deficit hyperactivity disorder be extended? Eur Neuropsychopharmacol. 2011;21(8):584-599.
5. Gevensleben H, Rothenberger A, Moll GH, et al. Neurofeedback in children with ADHD: validation and challenges. Expert Rev Neurother. 2012;12(4):447-460.
6. Monastra VJ, Lynn S, Linden M, et al. Electroencephalographic biofeedback in the treatment of attention-deficit/hyperactivity disorder. Appl Psychophysiol Biofeedback. 2005;30(2):95-114.
7. Barry RJ, Clarke AR, Johnstone SJ. A review of electrophysiology in attention-deficit/hyperactivity disorder, 1: qualitative and quantitative electroencephalography. Clin Neurophysiol. 2003;114(2):171-183.
8. Lofthouse N, Arnold LE, Hurt E. Current status of neurofeedback for attention-deficit/hyperactivity disorder. Curr Psychiatry Rep. 2012;14(5):536-542.
9. Moriyama TS, Polanczyk G, Caye A, et al. Evidence-based information on the clinical use of neurofeedback for ADHD. Neurotherapeutics. 2012;9(3):588-598.
10. Lofthouse N, Arnold LE, Hersch S, et al. A review of neurofeedback treatment for pediatric ADHD. J Atten Disord. 2012;16(5):351-372.
11. Arnold LE, Lofthouse N, Hersch S, et al. EEG neurofeedback for ADHD: double-blind sham-controlled randomized pilot feasibility trial. J Atten Disord. 2012;22(10):1-11.
12. Lansbergen MM, van Dongen-Boomsma M, Buitelaar JK, et al. ADHD and EEG-neurofeedback: a double-blind randomized placebo-controlled feasibility study. J Neural Transm. 2011;118(2):275-284.
13. Perreau-Linck E, Levesque J, Beauregard M. Effects of neurofeedback training on inhibitory capacities in ADHD children: a single-blind, randomized, placebo-controlled study. J Neurother. 2010;14(3):229-242.
14. Sonuga-Barke EJS, Brandeis D, Cortese S, et al European ADHD Guidelines Group. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry. 2013;170(3):275-289.
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
16. Zhang S, Faries DE, Vowles M, et al. ADHD Rating Scale IV: psychometric properties from a multinational study as a clinician-administered instrument. Int J Methods Psychiatr Res. 2005;14(4):186-201.
17. Berument SK, Rutter M, Lord C, et al. Autism Screening Questionnaire: diagnostic validity. Br J Psychiatry. 1999;175(5):444-451.
18. Shaffer D, Fisher P, Lucas CP, et al. NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry. 2000;39(1):28-38.
19. Steenhuis MP, Serra M, Minderaa RB, et al. An Internet version of the Diagnostic Interview Schedule for Children (DISC-IV): correspondence of the ADHD section with the paper-and-pencil version. Psychol Assess. 2009;21(2):231-234.
20. Shaffer D, Gould MS, Brasic J, et al. A Children's Global Assessment Scale (CGAS). Arch Gen Psychiatry. 1983;40(11):1228-1231.
21. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education, and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health; 1976:218-222.
22. Wechsler D. Manual for the Wechsler Intelligence Scale for Children. New York, NY: The Psychological Corporation; 1949.
23. Wechsler D. Wechsler Preschool and Primary Scale of Intelligence-Revised. New York, NY: The Psychological Corporation; 1989.
24. Wechsler D. Manual for the Wechsler Intelligence Scale for Children. 3rd ed. San Antonio, TX: The Psychological Corporation; 1991.
25. Thatcher R. EEG normative databases and EEG biofeedback. J Neurother. 1998;2(4):8-39.
26. Faraone SV, Buitelaar J. Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eur Child Adolesc Psychiatry. 2010;19(4):353-364.
27. Michelson D, Allen AJ, Busner J, et al. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry. 2002;159(11):1896-1901.
28. Fuchs T, Birbaumer N, Lutzenberger W, et al. Neurofeedback treatment for attention-deficit/hyperactivity disorder in children: a comparison with methylphenidate. Appl Psychophysiol Biofeedback. 2003;28(1):1-12.
29. Logemann HN, Lansbergen MM, Van Os TW, et al. The effectiveness of EEG-feedback on attention, impulsivity and EEG: a sham feedback controlled study. Neurosci Lett. 2010;479(1):49-53.
30. Pelham WE Jr, Carlson C, Sams SE, et al. Separate and combined effects of methylphenidate and behavior modification on boys with attention deficithyperactivity disorder in the classroom. J Consult Clin Psychol. 1993;61(3):506-515.
31. Sandler AD, Bodfish JW. Open-label use of placebos in the treatment of ADHD: a pilot study. Child Care Health Dev. 2008;34(1):104-110.
32. Sweere Y, Kerkhof GA, De Weerd AW, et al. The validity of the Dutch Sleep Disorders Questionnaire (SDQ). J Psychosom Res. 1998;45(6):549-555.